COMPASS PATHWAYS PLC Interest Expense on Debt
COMPASS PATHWAYS PLC (CMPS) reported Interest Expense on Debt of $2.90 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseDebt · last filed 2026-08-05
- COMPASS PATHWAYS PLC interest expense, debt for the quarter ending 2026-06-30 was $1.40M, a 0.00% change year-over-year.
- COMPASS PATHWAYS PLC interest expense, debt for the quarter ending 2026-03-31 was $1.50M, a 66.67% increase year-over-year.
- COMPASS PATHWAYS PLC interest expense, debt for the quarter ending 2025-12-31 was $1.10M, a 8.33% decline year-over-year.
- COMPASS PATHWAYS PLC interest expense, debt for the quarter ending 2025-09-30 was $1.10M, a 0.00% change year-over-year.
- COMPASS PATHWAYS PLC interest expense, debt for fiscal 2025 was $4.50M, a 0.00% change from fiscal 2024.
- COMPASS PATHWAYS PLC interest expense, debt for fiscal 2024 was $4.50M, a 104.55% increase from fiscal 2023.
- COMPASS PATHWAYS PLC interest expense, debt for fiscal 2023 was $2.20M.
| Period end | Interest Expense, Debt 3 month | Interest Expense, Debt 6 month | Interest Expense, Debt 6 month as first filed | Interest Expense, Debt 9 month | Interest Expense, Debt 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $2.90M 10-Q · filed 2026-08-05 | $4.00M derived: sum of 3 quarters · filed 2026-08-05 | $5.10M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | $1.50M 10-Q · filed 2026-05-13 | $2.60M derived: sum of 2 quarters · filed 2026-05-13 | $3.70M derived: sum of 3 quarters · filed 2026-05-13 | $5.10M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $2.20M derived: sum of 2 quarters · filed 2026-03-24 | $3.60M derived: sum of 3 quarters · filed 2026-08-05 | $4.50M 10-K · filed 2026-03-24 | |
| 2025-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $2.50M derived: sum of 2 quarters · filed 2026-08-05 | $3.40M 10-Q · filed 2025-11-04 | $4.60M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | $1.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $2.30M 10-Q · filed 2026-08-05 | $3.50M derived: sum of 3 quarters · filed 2026-08-05 | $4.60M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $900.00K 10-Q · filed 2026-05-13 | $2.10M derived: sum of 2 quarters · filed 2026-05-13 | $3.20M derived: sum of 3 quarters · filed 2026-05-13 | $4.30M derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | $1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $2.30M derived: sum of 2 quarters · filed 2026-03-24 | $3.40M derived: sum of 3 quarters · filed 2026-03-24 | $4.50M 10-K · filed 2026-03-24 | |
| 2024-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $2.20M derived: sum of 2 quarters · filed 2025-11-04 | $3.30M 10-Q · filed 2025-11-04 | $4.40M derived: sum of 4 quarters · filed 2025-11-04 | |
| 2024-06-30 | $1.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $2.20M 10-Q · filed 2025-07-31 | $3.30M derived: sum of 3 quarters · filed 2025-07-31 | $4.40M derived: sum of 4 quarters · filed 2025-07-31 | |
| 2024-03-31 | $1.10M 10-Q · filed 2025-05-08 | $2.20M derived: sum of 2 quarters · filed 2025-05-08 | $3.30M derived: sum of 3 quarters · filed 2025-05-08 | $3.30M derived: sum of 4 quarters · filed 2025-05-08 | |
| 2023-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $2.20M derived: sum of 2 quarters · filed 2025-02-27 | $2.20M derived: sum of 3 quarters · filed 2025-02-27 | $2.20M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $1.10M derived: sum of 2 quarters · filed 2024-10-31 | $1.10M 10-Q · filed 2024-10-31 | ||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $0.00 10-Q · filed 2024-08-01 | $100.00K 10-Q · filed 2023-08-03 | ||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |